FIG
CLVS

Fortress Investment Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Fortress Investment Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-30,000
Closed -$2.01M – 197
2013
Q2 		$2.01M Buy
+30,000
New +$1.35M 0.05% 49

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fortress Investment Group's CLVS Position: Q3 2013 in Review

Fortress Investment Group sold out of Clovis Oncology, Inc. (CLVS) in Q3 2013, closing a stake of 30,000 shares — an estimated $2.01M sold.

Fortress Investment Group first reported a position in CLVS in Q2 2013 and held it in 1 quarter. The position peaked at $2.01M in Q2 2013. 116 funds tracked by Wall St. Rank hold CLVS as of Q3 2013.

  • Fortress Investment Group reported no remaining Clovis Oncology, Inc. position as of Q3 2013 after selling out during the quarter.
  • Fortress Investment Group sold 30,000 Clovis Oncology, Inc. shares in Q3 2013, an estimated $2.01M.
  • Fortress Investment Group first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 1 quarter.
  • Fortress Investment Group's Clovis Oncology, Inc. position peaked at $2.01M in Q2 2013.
  • 116 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2013.

Based on Fortress Investment Group's 13F filing for Q3 2013, filed 14 Nov 2013.